| http://www.w3.org/ns/prov#value | - Together, our results indicate that agonism of 5-HT2A receptors is a novel approach to developing small-molecule based therapeutics for inflammatory diseases that involve TNF-??, especially for those of the vasculature and gut such as atherosclerosis and inflammatory bowel disease.
|
